GSK4527226
219867
Phase 2 small_molecule active
Quick answer
GSK4527226 for Alzheimer's Disease is a Phase 2 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Alzheimer's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active